Clinical trial • Enrolling • 12 February 2013
Improving antiretroviral treatment (ART) initiation for people living with HIV in Australia: a realistic and viable approach? Sub-study 3: interviewing people diagnosed with HIV currently not on ART.
Tags: Understanding HIV treatments, living with HIV, starting treatments
Clinical trial • Enrolling • 11 February 2013
Clinical trial • Concluded • 7 February 2012
A Single Center, Open Label, Longitudinal Single Arm Study to Compare the Efficacy and Safety of Prophylactic Famciclovir 500 mg b.d. in HIV Positive Adults With Recurrent Genital Herpes.
Tags: genital herpes
Clinical trial • Enrolling • 7 February 2012
A Phase 3, Open Label Study of Safety and Efficacy With BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected With Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)
Clinical trial • Concluded • 24 January 2012
Non-nucleoside Reverse Transcriptase Inhibitor Failure in a High HIV Caseload Australian Primary Care Practice
Clinical trial • No longer enrolling • 19 January 2012
A Multicenter, Randomized, Double Blind, Comparative Trial Of Maraviroc + Darunavir/Ritonavir Versus Emtricitabine/Tenofovir +Darunavir/Ritonavir For The Treatment Of Antiretroviral-Naïve HIV Infected Patients With Ccr5 Tropic HIV 1
Tags: maraviroc
Clinical trial • Fully enrolled • 16 January 2012
A Phase 3 Open-label Safety Study of Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Clinical trial • Reported • 16 January 2012
An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men
Tags: anal cancer, HPV
Clinical trial • Enrolling • 23 November 2011
Effectiveness of Team Intervention Over 12 Months in Reducing Modifiable CVD Risk Factors on Framingham 10yr Risk Scores Outcomes in HIV-1 Subjects on Antiretroviral Therapy
Clinical trial • Fully enrolled • 23 November 2011
The CNS HAND Study: The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort
Clinical trial • Fully enrolled • 19 October 2011
AHOD Temporary Residents Access Study
Clinical trial • Enrolling • 18 October 2011
A randomised, open-label study to evaluate the efficacy and safety of maraviroc (MVC) as a switch for either nucleoside or nucleotide analogue reverse transcriptase inhibitors (N(t)RTI) or boosted protease inhibitors (PI/r) in HIV-1 infected individuals with stable, well-controlled plasma HIV-RNA while taking their first N(t)RTI + PI/r regimen of combination antiretroviral therapy (cART)
Clinical trial • Cancelled • 25 March 2011
A Long Term Open-Label Extension Study of Lersivirine For The Treatment Of HIV-1 Infection
Clinical trial • Enrolling • 24 March 2011
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir-boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)-Naive Adults
Tags: heart disease
This site complies with the HONcode standard for trustworthy health information: verify here. 